Literature DB >> 22956985

Deletion of the huntingtin proline-rich region does not significantly affect normal huntingtin function in mice.

Michelle Neveklovska1, Erin B D Clabough, Joan S Steffan, Scott O Zeitlin.   

Abstract

The N-terminus of Huntingtin, the protein encoded by the Huntington's disease gene, contains a stretch of polyglutamine residues that is expanded in Huntington's disease. The polyglutamine stretch is flanked by two conserved protein domains in vertebrates: an N1-17 domain, and a proline-rich region (PRR). The PRR can modulate the structure of the adjacent polyglutamine stretch, and is a binding site for several interacting proteins. To determine the role of the PRR in Huntingtin function, we have generated a knock-in allele of the mouse Huntington's disease gene homolog that expresses full-length normal huntingtin lacking the PRR. Mice that are homozygous for the huntingtin PRR deletion are born at the normal Mendelian frequency, suggesting that the PRR is not required for essential huntingtin functions during embryonic development. Moreover, adult homozygous mutants did not exhibit any significant differences from wild-type controls in general motor function and motor learning. However, 18 month-old male, but not female, homozygous PRR deletion mutants exhibited deficits in the Morris water task, suggesting that age-dependent spatial learning and memory may be affected in a sex-specific fashion by the huntingtin PRR deletion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22956985      PMCID: PMC3432989          DOI: 10.3233/JHD-2012-120016

Source DB:  PubMed          Journal:  J Huntingtons Dis        ISSN: 1879-6397


  59 in total

Review 1.  The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains.

Authors:  B K Kay; M P Williamson; M Sudol
Journal:  FASEB J       Date:  2000-02       Impact factor: 5.191

2.  The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.

Authors:  J S Steffan; A Kazantsev; O Spasic-Boskovic; M Greenwald; Y Z Zhu; H Gohler; E E Wanker; G P Bates; D E Housman; L M Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 3.  WW and SH3 domains, two different scaffolds to recognize proline-rich ligands.

Authors:  Maria J Macias; Silke Wiesner; Marius Sudol
Journal:  FEBS Lett       Date:  2002-02-20       Impact factor: 4.124

4.  Huntingtin's WW domain partners in Huntington's disease post-mortem brain fulfill genetic criteria for direct involvement in Huntington's disease pathogenesis.

Authors:  L A Passani; M T Bedford; P W Faber; K M McGinnis; A H Sharp; J F Gusella; J P Vonsattel; M E MacDonald
Journal:  Hum Mol Genet       Date:  2000-09-01       Impact factor: 6.150

5.  Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice.

Authors:  I Dragatsis; M S Levine; S Zeitlin
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

6.  Nuclear relocation of normal huntingtin.

Authors:  T Tao; A M Tartakoff
Journal:  Traffic       Date:  2001-06       Impact factor: 6.215

7.  PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington's disease brains.

Authors:  Jan Modregger; Nicholas A DiProspero; Vinod Charles; Danilo A Tagle; Markus Plomann
Journal:  Hum Mol Genet       Date:  2002-10-01       Impact factor: 6.150

8.  Huntingtin bodies sequester vesicle-associated proteins by a polyproline-dependent interaction.

Authors:  Zheng-Hong Qin; Yumei Wang; Ellen Sapp; Benjamin Cuiffo; Erich Wanker; Michael R Hayden; Kimberly B Kegel; Neil Aronin; Marian DiFiglia
Journal:  J Neurosci       Date:  2004-01-07       Impact factor: 6.167

9.  Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington's disease and depression.

Authors:  Thibault Renoir; Michelle S Zajac; Xin Du; Terence Y Pang; Leah Leang; Caroline Chevarin; Laurence Lanfumey; Anthony J Hannan
Journal:  PLoS One       Date:  2011-07-08       Impact factor: 3.240

10.  Huntingtin gene evolution in Chordata and its peculiar features in the ascidian Ciona genus.

Authors:  Carmela Gissi; Graziano Pesole; Elena Cattaneo; Marzia Tartari
Journal:  BMC Genomics       Date:  2006-11-08       Impact factor: 3.969

View more
  11 in total

1.  A large scale Huntingtin protein interaction network implicates Rho GTPase signaling pathways in Huntington disease.

Authors:  Cendrine Tourette; Biao Li; Russell Bell; Shannon O'Hare; Linda S Kaltenbach; Sean D Mooney; Robert E Hughes
Journal:  J Biol Chem       Date:  2014-01-09       Impact factor: 5.157

2.  Characterization of a Knock-In Mouse Model with a Huntingtin Exon 1 Deletion.

Authors:  Elise M Braatz; Emily A André; Jeh-Ping Liu; Scott O Zeitlin
Journal:  J Huntingtons Dis       Date:  2021

3.  Ablation of huntingtin in adult neurons is nondeleterious but its depletion in young mice causes acute pancreatitis.

Authors:  Guohao Wang; Xudong Liu; Marta A Gaertig; Shihua Li; Xiao-Jiang Li
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-07       Impact factor: 11.205

4.  N17 Modifies mutant Huntingtin nuclear pathogenesis and severity of disease in HD BAC transgenic mice.

Authors:  Xiaofeng Gu; Jeffrey P Cantle; Erin R Greiner; C Y Daniel Lee; Albert M Barth; Fuying Gao; Chang Sin Park; Zhiqiang Zhang; Susana Sandoval-Miller; Richard L Zhang; Marc Diamond; Istvan Mody; Giovanni Coppola; X William Yang
Journal:  Neuron       Date:  2015-02-05       Impact factor: 17.173

5.  Generation and Characterization of Knock-in Mouse Models Expressing Versions of Huntingtin with Either an N17 or a Combined PolyQ and Proline-Rich Region Deletion.

Authors:  Emily A André; Elise M Braatz; Jeh-Ping Liu; Scott O Zeitlin
Journal:  J Huntingtons Dis       Date:  2017

Review 6.  Huntington Disease as a Neurodevelopmental Disorder and Early Signs of the Disease in Stem Cells.

Authors:  Kalina Wiatr; Wojciech J Szlachcic; Marta Trzeciak; Marek Figlerowicz; Maciej Figiel
Journal:  Mol Neurobiol       Date:  2017-05-11       Impact factor: 5.590

7.  Demonstration of prion-like properties of mutant huntingtin fibrils in both in vitro and in vivo paradigms.

Authors:  Maria Masnata; Giacomo Sciacca; Alexander Maxan; Luc Bousset; Hélèna L Denis; Florian Lauruol; Linda David; Martine Saint-Pierre; Jeffrey H Kordower; Ronald Melki; Melanie Alpaugh; Francesca Cicchetti
Journal:  Acta Neuropathol       Date:  2019-02-20       Impact factor: 17.088

8.  N-terminal Huntingtin Knock-In Mice: Implications of Removing the N-terminal Region of Huntingtin for Therapy.

Authors:  Xudong Liu; Chuan-En Wang; Yan Hong; Ting Zhao; Guohao Wang; Marta A Gaertig; Miao Sun; Shihua Li; Xiao-Jiang Li
Journal:  PLoS Genet       Date:  2016-05-20       Impact factor: 5.917

9.  Altered Co-Translational Processing Plays a Role in Huntington's Pathogenesis-A Hypothesis.

Authors:  Daniel A Nissley; Edward P O'Brien
Journal:  Front Mol Neurosci       Date:  2016-07-06       Impact factor: 5.639

Review 10.  Huntington's disease: the past, present, and future search for disease modifiers.

Authors:  Erin B D Clabough
Journal:  Yale J Biol Med       Date:  2013-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.